Evaluating Nasal Pumps: Priming, Fill and Meaningful Endpoints

Start with a measurable claim

“The pump works” is not a useful experimental endpoint. It could mean that the device produces a mist, expels a repeatable liquid mass or delivers a repeatable amount of a specified compound. Those claims require different evidence.

For content delivery, the central endpoint is the analytically measured amount of compound expelled per actuation under defined conditions. Output mass is a complementary engineering measurement, not a substitute for chemical analysis. Spray-pattern or droplet measurements describe other aspects of performance; neither establishes systemic exposure.

Treat operating conditions as study variables

A meaningful evaluation identifies the pump model, container, formulation, fill and handling conditions. Changing one of these can change the system being evaluated. Results from a pump tested with one liquid do not automatically validate another formulation.

Priming and re-priming are particularly important sources of ambiguity. Testing must distinguish the device's specified operating state from measurements obtained outside that state. There is no universal priming count that can be inferred from nozzle design, and this engineering discussion does not supply one.

The Health Canada guidance on inhalation and nasal product quality is a regulatory framework for evaluating these questions, including delivered-dose uniformity across container life. It is not a study demonstrating performance of any product discussed here.

Averages can conceal the relevant failure

Consider a hypothetical evaluation in which early and middle measurements are close to the intended output, but late-container measurements decline. An overall average could obscure that pattern. Reporting results by container stage helps distinguish repeatable metering from performance that depends on how much liquid remains.

Similarly, repeated measurements from one bottle characterize that bottle more directly than they characterize variation among units. A well-described study separates within-container variation from between-container variation and identifies how residual liquid and the claimed number of usable actuations were assessed. Nominal fill alone cannot establish that count.

Analytical methods must also be fit for their intended purpose. An assay used to quantify delivered content needs appropriate validation; visual consistency cannot compensate for an unsuitable measurement method.

Keep the conclusion within the endpoint

A successful device evaluation supports only the formulation, assembly and conditions examined. It does not establish tissue uptake, clinical efficacy or stability over an untested storage period.

The related guides address those separate questions: label interpretation distinguishes nominal quantities, formulation assessment examines vehicle and container considerations, and nasal delivery mechanisms explains the barriers between expelled material and measured biological exposure.